Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,137.50    20.50 (1.84%)
Bid:
1,129.50
Ask:
1,132.50
Spread: 3.00 (0.266%)
Market Cap: £4.09b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Board Change

15 Jul 2024 07:00

RNS Number : 3173W
Burberry Group PLC
15 July 2024
 

15 July 2024

BURBERRY GROUP PLC

("Burberry" or the "Company")

 

BOARD CHANGE

 

Burberry today announces the appointment of Joshua Schulman as Chief Executive Officer and Executive Director. Joshua replaces Jonathan Akeroyd who is stepping down and leaving the Company with immediate effect by mutual agreement with the Board.

An American national, Joshua, 52, joins Burberry with a track record of driving transformative growth and value creation as CEO of global luxury, fashion, and retail businesses.

Joshua was previously CEO of American fashion brands Michael Kors (2021-2022) and Coach where he also served as Brand President (2017-2020). Prior to this, at Neiman Marcus Group, he was President of Bergdorf Goodman for five years. From 2007 to 2012, Joshua was CEO of Jimmy Choo in London. Earlier, Joshua was Executive Vice President/ Worldwide Merchandising and Sales at Yves Saint Laurent and Worldwide Director/ Women's Ready To Wear at Gucci.

Joshua will join Burberry on 17 July 2024 and be based at the Company's headquarters in London. He will lead the Executive Committee and report to Burberry Chair Gerry Murphy and the Board of Directors.

Gerry Murphy commented: "I am pleased that Josh will be joining Burberry as our new Chief Executive Officer. Josh is a proven leader with an outstanding record of building global luxury brands and driving profitable growth. He has a strong understanding of our brand and shares our ambition to build on Burberry's unique creative heritage. His extensive experience in luxury and fashion will be key to realising Burberry's full potential."

"I would like to take this opportunity to thank Jonathan Akeroyd for the contribution he has made to Burberry. Jonathan has set out a clear strategy for growth that we will build on."

Joshua Schulman commented: "I am deeply honoured to join Burberry as Chief Executive Officer. Burberry is an extraordinary luxury brand, quintessentially British, equal parts heritage and innovation. Its original purpose to protect people from the weather is more relevant than ever. I look forward to working alongside Daniel Lee and the talented teams to drive global growth, delight our customers, and write the next chapter of the Burberry story."

This announcement contains information that qualified or may have qualified as inside information for the purposes of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). For the purposes of MAR, the person responsible for the release of this announcement on behalf of Burberry is Gemma Parsons, Company Secretary.

There are no other matters to be disclosed under listing rule 9.6.13R in relation to Joshua's appointment.

Additional information

About Joshua Schulman

· As CEO and Brand President of Coach, Joshua led a brand transformation focused on global cultural relevance, product innovation and digital growth, resulting in an inflection in sales and operating income.

· At Neiman Marcus Group, he was President of Bergdorf Goodman where he energised the New York retailer by renovating the landmark flagship while driving digital growth. Concurrently, he spearheaded the acquisition of MyTheresa.com.

· As CEO of Jimmy Choo, Joshua led the evolution of the shoe specialist into a global luxury brand. With a strategy of icons and innovation, he expanded the company's global footprint, growing sales and EBITDA 4X in five years.

· Joshua has also been on the board of Zimmermann, the Australian luxury brand and was a non-executive director of Farrow & Ball, the UK-based luxury paint and wall covering brand.

· Joshua attended New York University and Parsons School of Design. 

· Originally from Los Angeles, he is relocating to London from New York City.

 

Remuneration Arrangements

Joshua Schulman's remuneration arrangements have been set in accordance with the Directors' Remuneration Policy approved by shareholders at the AGM on 12 July 2023. His salary will be £1,200,000 per annum and he will be eligible for a target bonus of 100% of salary and maximum of 200% of salary and a Burberry Share Plan award of 162.5% of salary. His pension entitlement will align with arrangements for the majority of the UK workforce. On joining, he will be granted a recruitment share award of 300% of salary which is due to vest three years from his commencement date subject to a two-year holding period based on achieving performance conditions linked to shareholder value creation. The Company will also pay his costs associated with his relocation from New York. Full details will be disclosed in Burberry's FY 2024/25 Annual Report. 

 

 

Jonathan Akeroyd's departure will be treated in accordance with the Directors' Remuneration Policy and his service contract. He will not be eligible for a bonus for the current financial year and all unvested share awards will lapse in full. Full details will be disclosed on Burberry's website in compliance with Section 430(2B) of the Companies Act 2006 and in the Directors' Remuneration Report within the Company's Annual Report and Accounts for the year ended March 2025.

Annual General Meeting

As the Company's notice of Annual General Meeting 2024 (the "Notice") has already been issued, the Company confirms that resolution 5 to re-elect Jonathan Akeroyd as a director of the Company is now withdrawn. The withdrawal of this resolution does not otherwise affect the validity of the Notice, the proxy form or any proxy votes already submitted or any other resolutions. The numbering of all other resolutions proposed at the Annual General Meeting will remain unchanged. Any votes already cast in relation to resolution 5 are of no effect.

ENQUIRIES

Investors and analysts

020 3367 3524

Lauren Wu Leng

Head of Investor Relations

lauren.wuleng@burberry.com

Media

020 3367 3764

Andrew Roberts

SVP, Corporate Relations and Engagement

andrew.roberts@burberry.com

 

· This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Burberry Group plc shares, in the UK, or in the US, or under the US Securities Act 1933 or in any other jurisdiction.

· Burberry is a British luxury brand, headquartered in London

· Burberry is listed on the London Stock Exchange (BRBY.L) and is a constituent of the FTSE 100 index. ADR symbol OTC:BURBY. BURBERRY, the Equestrian Knight Device, the Burberry Check, and the Thomas Burberry Monogram and Print are trademarks belonging to Burberry.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOARIMLTMTTBBJI
Date   Source Headline
10th Jun 20264:52 pmRNSDirector Declaration
9th Jun 202611:30 amRNSHolding(s) in Company
1st Jun 202610:15 amRNSIssue of Shares & Total Voting Rights
28th May 202610:45 amRNSAnnual Financial Report
14th May 20267:01 amRNSBoard changes
14th May 20267:00 amRNSBurberry FY26 Preliminary Results
1st May 202612:20 pmRNSIssue of Shares & Total Voting Rights
29th Apr 20262:45 pmRNSDirector Declaration
10th Apr 20263:40 pmRNSHolding(s) in Company
9th Apr 202611:30 amRNSHolding(s) in Company
1st Apr 20265:30 pmRNSIssue of Shares & Total Voting Rights
1st Apr 202612:15 pmRNSHolding(s) in Company
20th Mar 202612:31 pmRNSDirector/PDMR Shareholding
20th Mar 202610:25 amRNSIssue of Equity
19th Mar 20266:00 pmRNSHolding(s) in Company
5th Mar 20264:40 pmRNSHolding(s) in Company
2nd Mar 202611:00 amRNSTotal Voting Rights
12th Feb 20262:00 pmRNSHolding(s) in Company
10th Feb 202610:30 amRNSHolding(s) in Company
2nd Feb 20262:00 pmRNSTotal Voting Rights
27th Jan 20265:00 pmRNSHolding(s) in Company
22nd Jan 202612:30 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSThird Quarter Trading Update
9th Jan 202612:30 pmRNSHolding(s) in Company
2nd Jan 202611:30 amRNSTotal Voting Rights
18th Dec 20252:01 pmRNSHolding(s) in Company
18th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20259:15 amRNSDirector/PDMR Shareholding
2nd Dec 20255:40 pmRNSHolding(s) in Company
1st Dec 20251:30 pmRNSTotal Voting Rights
24th Nov 20255:30 pmRNSHolding(s) in Company
20th Nov 20254:20 pmRNSHolding(s) in Company
19th Nov 20255:36 pmRNSHolding(s) in Company
18th Nov 20256:07 pmRNSHolding(s) in Company
13th Nov 20255:27 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSBurberry Interim Results
3rd Nov 20252:43 pmRNSTotal Voting Rights
28th Oct 20254:50 pmRNSHolding(s) in Company
15th Oct 20255:38 pmRNSHolding(s) in Company
10th Oct 202512:07 pmRNSHolding(s) in Company
2nd Oct 20253:10 pmRNSHolding(s) in Company
1st Oct 202510:30 amRNSTotal Voting Rights
25th Sep 20256:00 pmRNSHolding(s) in Company
5th Sep 20256:21 pmRNSBlock listing Interim Review
5th Sep 20255:45 pmRNSDirector/PDMR Shareholding
1st Sep 202512:14 pmRNSTotal Voting Rights
13th Aug 20253:04 pmRNSHolding(s) in Company
1st Aug 202511:58 amRNSTotal Voting Rights
31st Jul 20254:55 pmRNSDirector/PDMR Shareholding
18th Jul 20255:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.